TCPG
RMD icon

Trivant Custom Portfolio Group’s ResMed RMD Stock Holding History

Trivant Custom Portfolio Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Sell
4,657
-308
-6% -$63.8K 0.48% 63
2026
Q1 		$1.11M Buy
4,965
+128
+3% +$31.9K 0.61% 47
2025
Q4 		$1.17M Buy
4,837
+40
+0.8% +$10.2K 0.67% 46
2025
Q3 		$1.31M Buy
4,797
+73
+2% +$19.9K 0.67% 45
2025
Q2 		$1.22M Buy
4,724
+36
+0.8% +$8.59K 0.67% 45
2025
Q1 		$1.05M Buy
+4,688
New +$1.09M 0.6% 48

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Trivant Custom Portfolio Group's RMD Position: Q2 2026 in Review

Trivant Custom Portfolio Group reduced its ResMed (RMD) stake by 6.2% in Q2 2026, selling an estimated $63.8K and leaving 4,657 shares worth $908K. The position accounts for 0.48% of the portfolio, ranked #63.

Trivant Custom Portfolio Group first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.31M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Trivant Custom Portfolio Group held 4,657 shares of ResMed worth $908K as of Q2 2026.
  • Trivant Custom Portfolio Group sold 308 ResMed shares in Q2 2026, an estimated $63.8K.
  • ResMed made up 0.48% of Trivant Custom Portfolio Group's portfolio in Q2 2026, its #63 holding.
  • Trivant Custom Portfolio Group first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Trivant Custom Portfolio Group's ResMed position peaked at $1.31M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2026, filed 27 Jul 2026.